Genesys International Corporation Board Approves Rights Issue of Equity Shares Up To Rs 13,930 Lakhs
Genesys International Corporation Limited has approved the issuance of equity shares through a rights issue. The decision was taken by the company's Board of Directors during a meeting held on Friday, June 26, 2026.The Board considered and approved the matter of issuing Equity Shares of the company for up to Rs 13,930 Lakhs. The approved equity shares have a face value of Rs 5/- each.
Alongside approving the rights issue, the directors also ratified the constitution of a Rights Issue Committee. This committee is responsible for the process related to the offer, allotment of Equity Shares, and any other matters associated with the rights issue.
The specific terms concerning the rights issue—including the determination of the issue price, the rights entitlement ratio, the record date, and payment terms—will be set by the Board or a duly constituted Committee authorized for this purpose.
The key details of the proposed issuance are as follows:
| Particulars | Details |
|---|---|
| Type of Security Proposed | Equity Shares |
| Type of Issuance | Rights Issue |
| Maximum Issue Amount | Up to and not exceeding Rs 13,930 Lakhs |
GENESYS Stock Price Movement
Shares of Genesys International Corporation Limited slipped on Thursday, settling at ₹326.5 after dropping 8.48%, or ₹30.20. The stock saw high trading activity with a total volume of 586,719 shares recorded during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.